ReviewInternational journal of molecular sciences2021

Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy.

Karen M Delgado-Minjares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.